echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New immune checkpoint for pancreatic cancer discovered

    New immune checkpoint for pancreatic cancer discovered

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent years, immune checkpoint blocking therapy has shown success in the treatment of many types of tumors, but it has been helpless against pancreatic cancer, which is known as the "king of cancer


    For a long time, immune checkpoint blocking therapy based on programmed death receptors and their ligands has not worked against pancreatic cancer


    Through a variety of sequencing and screening, the research team found that osteopontin and its ligands are another immune checkpoint besides the programmed death receptor and its ligands, which promote the development of pancreatic cancer by compensating for the function of the programmed death receptor.


    Studies have found that the inhibitor WDR5-47 can effectively inhibit the expression of osteopontin in pancreatic tumor cells and myeloid-derived suppressor cells, and has great potential to be developed as an immunotherapy monotherapy for the treatment of pancreatic cancer


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.